Agarwal Toughened Glass India Limited has informed the Exchange regarding Board meeting held on December 08, 2025.

Agarwal Toughened Glass India Limited has informed the Exchange regarding Resignation of Ms TANVI MARU as Company Secretary & Compliance Officer of the company w.e.f. December 08, 2025.

Clarification on recent media publication appearing on "www.moneycontrol.com" dated December 05, 2025 captioned "Cloudfare down: Outage hits trading platforms like Zerodha Groww and others"

With reference to the Public Announcement dated September 04, 2025, Detailed Public Statement on September 12, 2025 and Draft Letter of Offfer dated September 19, 2025, Kunvarji Finstock Pvt Ltd ("Manager to the Offer") has now informed BSE that the identified date for the purpose of determining the names of the shareholders to whom the Letter of Offer would be sent is fixed as December 09, 2025.

Inter alia, approved the appointment of Ms. Parakh Patel (Membership Number: A37027) as Company Secretary and Compliance Officer of the Company w.e.f., December 08, 2025.

Inter-alia, transacted the following business:- 1. Increase in Authorised Share Capital and consequential amendment to the Memorandum of Association of the Company: Approved the increase in the authorised share capital of the Company from existing Rs. 7,00,00,00,000 (Rupees Seven Hundred Crores Only) divided into 1,40,00,00,000 (One Hundred and Forty Crores) equity shares of Rs. 5/- (Rupees Five Only) each to Rs. 9,00,00,00,000 (Rupees Nine Hundred Crores Only) divided into 1,80,00,00,000 (One Hundred and Eighty Crores) equity shares of Rs. 5 each and consequential amendment to the capital clause of the Memorandum of Association, subject to the receipt of necessary approvals including approval of the Shareholders of the Company and other regulatory / statutory approvals, as may be required, in this regard. 2. Acquisition of equity shares of Biocon Biologics Limited and issuance of equity shares on a preferential basis: Approved the acquisition of the equity shares of Biocon Biologics Limited (?BBL?) by the Company, held by: (a) Mylan Inc. (?Mylan?); (b) Serum Institute Life Sciences Private Limited (?Serum?); (c) Tata Capital Growth Fund II (?TCGF?); and (d) Activ Pine LLP (?Activ Pine?) (collectively referred as ?Selling Shareholders/Proposed Allotees?) (?Proposed Transaction?), subject to requisite approvals, consents, permissions and sanctions as may be necessary from any statutory or regulatory authority or from shareholders, lenders, stock exchanges and depositories, and execution of definitive agreements (along with all schedules, annexure and ancillary documents) setting out the terms and conditions of the Proposed Transaction. With reference to the above, the Board approved the offer and issuance of 17,12,79,553 equity shares of the Company having face value of Rs. 5/- each, in one or more tranches, on a preferential basis (?Preferential Issue?) at a price which is not less than the price determined in accordance with the provisions of the Companies Act, 2013 and rules made thereunder, and Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and aggregating to an amount up to Rs. 6,950 Crores (Rupees Six Thousand Nine Hundred Fifty Crores Only) for consideration other than cash (i.e., swap of securities of BBL) to the Proposed Allottees, towards discharge of part/full consideration in connection with the Proposed Transaction, subject to the approval of the shareholders of the Company, the National Stock Exchange of India Limited, the BSE Limited and/or any other competent authorities, to the extent applicable and as may be required. 3. Fund Raising: Approved the raising of funds by way of issuance of any instrument or security, including equity shares, non-convertible debt instruments along with warrants, any other convertible securities or any other eligible securities or any combination thereof (?Securities?), by way of qualified institutions placement(s) (?QIP?), rights issue, preferential allotment or private placement(s) and/or any combination thereof or any other method as may be permitted under applicable laws, and on such terms and conditions as may be considered appropriate by the Board in its absolute discretion under applicable laws, for an aggregate amount of up to Rs. 4,500 Crores, in one or more tranches and/or one or more issuances, mainly towards cash consideration payable to Mylan, subject to the receipt of necessary approvals including approval of the Shareholders of the Company and other regulatory / statutory approvals, as may be required, in this regard. 4. Convening of Extra-Ordinary General Meeting (EGM): In connection with each of the above, the Board approved convening of an Extra-Ordinary General Meeting (?EGM?) of the shareholders of the Company on Wednesday, December 31, 2025 through video conferencing (?VC?) or other audio-visual means (?OVAM?), for seeking necessary approval of the Shareholders for the aforesaid matters. The Notice of EGM shall be communicated in due course. Accordingly, the relevant date, in terms of provision of ICDR Regulations for determining the floor price of the Preferential Issue, is Monday, December 1, 2025. 5. Issuance of Commercial Papers: Approved issuance of Commercial Papers for an amount up to Rs. 1,800 Crores (Rupees One Thousand Eight Hundred Crores) in one or more tranches on private placement basis, in order to discharge the cash remittance to Mylan in the interim, till the completion of fund raise as detailed in Item No. 3 above.

Cell Point (India) Limited has informed the Exchange regarding Board meeting held on December 08, 2025 Seeking shareholders approval by way of postal ballot for appointment of Mrs. SAILAJA PENMETSA (DIN: 11354469), as an Independent Director of the Company

Chavda Infra Limited has informed the Exchange regarding Board meeting held on December 08, 2025.

Chetana Education Limited has informed the Exchange regarding a press release dated December 05, 2025, titled "Press release regarding Credit Rating under Regulation 30 of the SEBI Listing Regulations".

Inter alia, considered and approved the following matters namely: 1.The Board noted that certain agenda items required further information/clarifications. Accordingly, the Board resolved to adjourn discussion on pending agenda items to the next Board Meeting. The revised date and time of the adjourned meeting will be communicated separately. 2.The Board took on record the resignation tendered by Ms. Sarita Soni (DIN: 08998686) Independent Director, due to pre-occupation, and approved her resignation with effect from 8th December 2025. The Board placed on record its appreciation for her valuable contribution during her tenure with the Company. 3.Based on the recommendation of the Nomination and Remuneration Committee (NRC), the Board approved the appointment of Mr. Dr. Madan Bhalchandra Gosavi, Mr.Charuhas Patil and Mr.Amit Doshi as an Additional Director, (Designated as Non-executive Independent Director) of the company with effect from 8th December, 2025 for the period of 3 years subject to the approval of shareholders of the Company in ensuing general meeting. A brief profile of the appointee is enclosed in Annexure-A as required under SEBI LODR. 4.The Board approved the re-constitution of the following committees: 1. Audit Committee 2. Nomination and Remuneration Committee 3. Stakeholders Relationship Committee

Inter alia, to consider and approve:- 1. To consider and approve appointment of Independent Director(s). 2. To consider and discuss any other business with the permission of the chairman.

Digikore Studios Limited has informed the Exchange regarding 'Sticky Revenues Ahead: Digikore s Exclusive Netflix Team Goes Live'.

The Exchange has sought clarification from Eldeco Housing & Industries Ltd on December 8, 2025 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.

Envirotech Systems Limited has informed the Exchange regarding 'Disclosure under Regulation 7(2) read with Regulation 6(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015'.

Inter alia to consider and approve the voluntary delisting of the company's equity shares from the Calcutta Stock Exchange Limited (CSE) in compliance with Regulations 5 & 6 of the SEBI (Delisting of Equity Shares) Regulations, 2021

Inter alia, to consider and approve:- 1. To consider and approve the re-appointment of the following Independent Directors for a second term of 5 years: Mr. Darshil Hemendrakumar Shah (DIN: 09013533) and Mr. Nigambhai Govindbhai Sathavara (DIN: 09016786), whose present term expires on 31st December 2025, subject to approval of the shareholders through Postal Ballot. 2. To consider and approve the draft Postal Ballot Notice and Explanatory Statement. 3. To consider appointment of Scrutinizer for conducting the Postal Ballot process. 4. To consider approval of e-voting facility through NSDL/ CDSL for Postal Ballot. 5. Any other business with the permission of the Chairperson.

Inter alia, has considered and approved the following: 1. The Board Approved the Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects , subject to the approval of shareholders of the Company. 2. The Board approved the increase in the Authorised Share Capital of the Company from Rs. 15,00,00,000 (Rupees Fifteen Crore Only) divided into 1,50,00,000 (Rupees One Crore Fifty Lakhs) Equity Shares of Rs. 10/- each to Rs. 100,00,00,000 (Rupees One Hundred Crore Only) divided into 10,00,00,000 (Rupees Ten Crore) Equity Shares of Rs. 10/- each and consequent amendment in the Capital Clause (Clause V) of Memorandum of Association of the Company, subject to approval of the shareholders of the Company. 3. Conduct Postal Ballot by means of E-voting for obtaining approval of the members of the Company for approval following items. (i) To Approve Alteration in Main Objects Clause of Memorandum of Association of the Company by addition of New Objects (ii) To Approve the increase in the Authorised Share Capital of the Company. 4. Appointed M/s Arvind Sudra and Associates, a Practicing Company Secretary, as the Scrutinizer for the aforesaid Postal Ballot process. The said notice may be accessed on the website of Company i.e. www.gravityindialtd.com & Stock Exchange i.e. www.bseindia.com 5. Based on the recommendation of the Audit Committee, the Board of Directors of the Company noted and accepted the resignation of CS Krina Shah, Practicing Company Secretary, Secretarial Auditor of the Company (Membership No.: A66521, COP: 27764) who have resigned vide their resignation letter dated 08th December, 2025 informing that due to pre- occupation cease to continue as the Secretarial Auditors of the Company. The Audit Committee considered the detailed reason provided by CS Krina Shah, for resignation as the Secretarial Auditors of the Company, the members of Audit Committee have considered the circumstance of resignation and the committee is aligned with the reasons stated in the resignation letter received from the Secretarial Auditor. The Audit Committee and Board members placed on record their appreciation to CS Krina Shah, Practicing Company Secretary, Secretarial Auditors for their contribution to the Company with their audit processes and standards of auditing. 6. The Board of Directors, upon accepting the resignation of the Secretarial Auditors dated 08th December, 2025, and based on the Audit Committee's recommendation, appointed M/s. Arvind Sudra & Associates, Practicing Company Secretary (Membership No. A19191, Firm Registration No. FRN: S2023GJ957800), as the new Statutory Auditors to fill the casual vacancy for the Financial Year 2025-26.

Gurunanak Agriculture India Limited has informed the Exchange regarding 'Clarification on Movement in Price'.

Hi-Green Carbon Limited has informed the Exchange regarding Board meeting held on December 08, 2025.

Preferential Issue of shares & Inter alia, to consider and evaluate, and if deemed appropriate, approve raising of funds through issue of securities / equity shares of the Company by way of preferential issue on a private placement basis, in accordance with the applicable provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, subject to receipt of necessary statutory / regulatory approvals, including approval of the shareholders of the Company.